Research progress on post-translational modification of proteins and cardiovascular diseases

被引:15
|
作者
Cheng, XueLi [1 ,2 ]
Wang, Kai [2 ]
Zhao, Yan [2 ]
Wang, Kun [1 ,2 ]
机构
[1] Qingdao Univ, Shandong Prov Maternal & Child Hlth Care Hosp, Key Lab Birth Regulat & Control Technol Natl Hlth, Jinan 250014, Shandong, Peoples R China
[2] Qingdao Univ, Affiliated Hosp, Inst Translat Med, Qingdao 266073, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
INDUCED CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; HEART-FAILURE; ACTIVATION; INJURY; METHYLATION; SUMOYLATION; EXPRESSION; PROTECTS; PATHWAY;
D O I
10.1038/s41420-023-01560-5
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cardiovascular diseases (CVDs) such as atherosclerosis, myocardial remodeling, myocardial ischemia-reperfusion (I/R) injury, heart failure, and oxidative stress are among the greatest threats to human health worldwide. Cardiovascular pathogenesis has been studied for decades, and the influence of epigenetic changes on CVDs has been extensively studied. Post-translational modifications (PTMs), including phosphorylation, glycosylation, methylation, acetylation, ubiquitination, ubiquitin-like and nitrification, play important roles in the normal functioning of the cardiovascular system. Over the past decade, with the application of high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS), an increasing number novel acylation modifications have been discovered, including propionylation, crotonylation, butyrylation, succinylation, lactylation, and isonicotinylation. Each change in protein conformation has the potential to alter protein function and lead to CVDs, and this process is usually reversible. This article summarizes the mechanisms underlying several common PTMs involved in the occurrence and development of CVDs.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Post-Translational Modification of Drp1 is a Promising Target for Treating Cardiovascular Diseases
    Ji, Yingjie
    Zhou, Han
    Yang, Chen
    Li, Jingjie
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2023, 8 (01)
  • [22] Impact of post-translational modification on the genesis and progression of diseases
    Wu, Zhuojun
    Jankowski, Joachim
    MOLECULAR ASPECTS OF MEDICINE, 2022, 86
  • [23] Post-Translational Adenosine Monophosphate (AMP) Modification of Proteins
    Worby, C. A.
    Mattoo, S.
    Kruger, R. P.
    Corbeil, L. B.
    Koller, A.
    Mendez, Juan C.
    Zekarias, B.
    Lazar, C.
    Dixon, Jack E.
    MOLECULAR & CELLULAR PROTEOMICS, 2009, : S26 - S26
  • [24] Monitoring post-translational modification of proteins with allosteric ribozymes
    Vaish, NK
    Dong, F
    Andrews, L
    Schweppe, RE
    Ahn, NG
    Blatt, L
    Seiwert, SD
    NATURE BIOTECHNOLOGY, 2002, 20 (08) : 810 - 815
  • [25] Post-translational modification of baculovirus-encoded proteins
    Chen, Nan
    Kong, Xiangshuo
    Zhao, Shudi
    Wu, Xiaofeng
    VIRUS RESEARCH, 2020, 279
  • [26] Post-translational modification of proteins during intermittent hypoxia
    Kumar, Ganesh K.
    Prabhakar, Nanduri R.
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2008, 164 (1-2) : 272 - 276
  • [27] Post-translational modification of proteins and the discovery of new medicine
    Parekh, RB
    Rohlff, C
    CURRENT OPINION IN BIOTECHNOLOGY, 1997, 8 (06) : 718 - 723
  • [28] Quantitative assessment of the post-translational modification of proteins in aging
    Richardson, A.
    FREE RADICAL RESEARCH, 2006, 40 : S49 - S49
  • [29] Monitoring post-translational modification of proteins with allosteric ribozymes
    Narendra K. Vaish
    Fang Dong
    Lori Andrews
    Rebecca E. Schweppe
    Natalie G. Ahn
    Lawrence Blatt
    Scott D. Seiwert
    Nature Biotechnology, 2002, 20 : 810 - 815
  • [30] Post-translational modification of PII signal transduction proteins
    Merrick, Mike
    FRONTIERS IN MICROBIOLOGY, 2015, 5